ASTUTE MEDICAL INC / BIOMERIEUX SA / Acquisition / Private / £64m

Synopsis

$90 million sale of Astute Medical, a pioneer of protein biomarker-derived diagnostic solutions, to bioMérieux, a publicly traded diagnostic company.

Principals

Astute Medical

Biomerieux

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

morrison & foerster

HQ - San Francisco

legal advisors

target

926

Deals

£ 565.38 B

Total Value